Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Patient with Type 2 Diabetes
98%
Diabetes
40%
Inpatient
38%
Diabetes Mellitus
29%
Patient
27%
Cardiovascular System
25%
Diabetic Retinopathy
22%
Cohort Analysis
19%
Pancreatic Stellate Cell
19%
Autonomic Neuropathy
17%
Cells
17%
Hemoglobin A1c
16%
Fibrosis
14%
Body Mass Index
13%
Follow up
13%
Glucose
12%
Insulin
12%
Autonomic Dysfunction
12%
Hypoglycemia
12%
Hazard Ratio
12%
Beta Cell
11%
Bone Density
11%
Hypoxia
10%
Programmed Cell Death
10%
Therapeutic Procedure
10%
Glomerular Filtration Rate
10%
Roux-en-Y Gastric Bypass
9%
Obesity
9%
Bariatric Surgery
9%
Oxidative Stress
9%
Hypoxic Injury
9%
Atherosclerosis
9%
Association
9%
Thyroid Cancer
9%
Lipoprotein
8%
In Vitro
7%
Cardiovascular Disease
7%
Chronic Kidney Disease
7%
Albuminuria
7%
Diabetic Nephropathy
7%
Visceral Fat
6%
Cell Proliferation
6%
Prevalence
6%
Sodium Glucose Cotransporter 2 Inhibitor
6%
Postmenopause
6%
Metabolic Syndrome
6%
Pancreatic Islet
6%
Dipeptidyl Peptidase-4 Inhibitor
6%
Thyroid Gland
6%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
75%
Non Insulin Dependent Diabetes Mellitus
34%
Diabetes Mellitus
21%
Hemoglobin A1c
15%
Cohort Study
13%
Lipoprotein A
12%
Diabetic Retinopathy
12%
Glucose
8%
Low Density Lipoprotein Cholesterol
7%
Bone Morphogenetic Protein
7%
Sulfonylurea
7%
Hypoglycemia
6%
Fibrosis
6%
Sodium Glucose Cotransporter 2 Inhibitor
6%
Diabetic Nephropathy
6%
Pig
6%
Denosumab
6%
Anagliptin
6%
Placebo
6%
Remission
5%
Dipeptidyl Peptidase IV Inhibitor
5%
Prevalence
5%
Bisphosphonic Acid Derivative
5%
Biochemistry, Genetics and Molecular Biology
Glucose
8%
Pig
7%
Lipid Profile
7%
Insulin
6%
Oxidative Stress
6%
Prospective Cohort Study
6%
Hemoglobin
6%
Insulin Resistance
5%
Body Mass
5%
Cohort Study
5%
Bone Density
5%
Glycosylated Hemoglobin
5%
